A Phase Ib Study of Preoperative, Locoregional IRX-2 Cytokine Immunotherapy to Prime Immune Responses in Patients with Early-Stage Breast Cancer-Reference-Cited by-同舟云学术

A Phase Ib Study of Preoperative, Locoregional IRX-2 Cytokine Immunotherapy to Prime Immune Responses in Patients with Early-Stage Breast Cancer

Published:2019-12-12 Issue:7 Volume:26 Page:1595-1605
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Page David B.,Pucilowska Joanna,Sanchez Katherine G.,Conrad Valerie K.,Conlin Alison K.,Acheson Anupama K.,Perlewitz Kelly S.,Imatani James H.,Aliabadi-Wahle Shaghayegh,Moxon Nicole,Mellinger Staci L.,Seino Amanda Y.,Martel Martiza,Wu Yaping,Sun Zhaoyu,Redmond William L.^ORCID,Rajamanickam Venkatesh^ORCID,Waddell Dottie,Laxague Deborah,Shah Monil,Chang Shu-Ching,Urba Walter J.

Funder

IRX

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantifiable TCR repertoire changes in prediagnostic blood specimens among patients with high-grade ovarian cancer;Cell Reports Medicine;2024-07

2. Phase Ib trial of IRX-2 plus durvalumab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma;Oral Oncology;2024-07

3. The Deep Learning Framework iCanTCR Enables Early Cancer Detection Using the T-cell Receptor Repertoire in Peripheral Blood;Cancer Research;2024-03-27

4. Trial watch: chemotherapy-induced immunogenic cell death in oncology;OncoImmunology;2023-06-03

5. Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches;Current Treatment Options in Oncology;2023-04-20